ImmuniWeb® Discovery vs Orpheus External Attack Surface Management: Side-by-Side Comparison (2026)

ImmuniWeb® Discovery: ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web. built by ImmuniWeb. Core capabilities include Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring..

Orpheus External Attack Surface Management: EASM platform with continuous asset discovery and threat intelligence context. built by Orpheus. Core capabilities include Continuous asset discovery across domains, APIs, and cloud services, Real-time external perimeter mapping, Threat intelligence integration with asset context..

Both serve the External Attack Surface Management market but differ in approach, feature depth, and target audience.

ImmuniWeb® Discovery differentiates with Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring. Orpheus External Attack Surface Management differentiates with Continuous asset discovery across domains, APIs, and cloud services, Real-time external perimeter mapping, Threat intelligence integration with asset context.

ImmuniWeb® Discovery is developed by ImmuniWeb. Orpheus External Attack Surface Management is developed by Orpheus. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

ImmuniWeb® Discovery and Orpheus External Attack Surface Management serve similar External Attack Surface Management use cases: both are External Attack Surface Management tools, both cover Dark Web Monitoring. Review the feature comparison above to determine which fits your requirements.